Bits in Bio Discussion: Genomics, Dx, and Data

​Genomics is moving from a diagnostic endpoint to a growing data layer for biology. Join for a conversation on how genomic diagnostics, data infrastructure, and AI are beginning to shape the next generation of bio.

​Speakers include:

​Mimi Lee: Former ARPA-H PM, physician-scientist, visionary thinker, artist, and healer committed to serving patients patient to serving patients.
Philip Fradkin - Co-Founder @ Blank Bio (YC S25)
Sophie Liu - Senior Director of Business Development @ Complete Genomics
Jessime Kirk - Co-Founder @ Stealth Dx

Sponsors:
​Bits in Bio connects the bioeconomy. We bring together innovators working at the intersection of software, AI, and biology. Our global community of over 12,000 members includes leading VCs, founders, and scientists.

Benchling is the leading AI platform for biotech R&D, unifying scientific data and automating workflows to accelerate discovery and development. Trusted by more than 1,300 companies worldwide, from pioneering startups to global leaders like Merck, Moderna, and Sanofi, Benchling gives scientists a single place to capture, connect, and act on data across the entire R&D lifecycle. With Benchling AI, agents and models work directly inside scientific workflows, grounded in structured data. The result is faster teams, better molecules, and breakthroughs that reach the world sooner.